Algert Global’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Sell |
68,081
-8,960
| -12% | -$322K | 0.05% | 569 |
|
|
2025
Q1 | $3.04M | Buy |
77,041
+27,980
| +57% | +$1.1M | 0.08% | 455 |
|
|
2024
Q4 | $1.48M | Sell |
49,061
-55,191
| -53% | -$1.66M | 0.03% | 704 |
|
|
2024
Q3 | $2.44M | Sell |
104,252
-42,966
| -29% | -$1M | 0.07% | 494 |
|
|
2024
Q2 | $2.62M | Buy |
147,218
+97,118
| +194% | +$1.73M | 0.09% | 380 |
|
|
2024
Q1 | $762K | Sell |
50,100
-970
| -2% | -$14.8K | 0.03% | 684 |
|
|
2023
Q4 | $872K | Sell |
51,070
-5,590
| -10% | -$95.4K | 0.04% | 656 |
|
|
2023
Q3 | $474K | Sell |
56,660
-43,271
| -43% | -$362K | 0.02% | 760 |
|
|
2023
Q2 | $2.48M | Buy |
99,931
+63,351
| +173% | +$1.57M | 0.11% | 325 |
|
|
2023
Q1 | $550K | Sell |
36,580
-150,449
| -80% | -$2.26M | 0.03% | 797 |
|
|
2022
Q4 | $2.21M | Buy |
187,029
+78,720
| +73% | +$931K | 0.12% | 264 |
|
|
2022
Q3 | $641K | Buy |
108,309
+8,639
| +9% | +$51.1K | 0.04% | 726 |
|
|
2022
Q2 | $424K | Buy |
+99,670
| New | +$424K | 0.03% | 810 |
|
|
2021
Q1 | – | Sell |
-12,208
| Closed | -$635K | – | 530 |
|
|
2020
Q4 | $635K | Buy |
+12,208
| New | +$635K | 0.18% | 183 |
|